Sei Investments CO Novo Cure LTD Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $193,814 - $407,993	3,434 Added 112.63%	6,483 $389,000
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $8,253 - $11,012	-129 Reduced 4.06%	3,049 $223,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $20,261 - $26,691	-298 Reduced 8.57%	3,178 $241,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $13,470 - $21,396	-238 Reduced 6.41%	3,476 $229,000
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $5,052 - $7,099	84 Added 2.31%	3,714 $306,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $45,573 - $74,047	607 Added 20.08%	3,630 $273,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $7,202 - $12,062	-62 Reduced 2.01%	3,023 $350,000
Q2 2021 Aug 06, 2021	SELL	$130.4 - $225.58 $877,852 - $1.52 Million	-6,732 Reduced 68.57%	3,085 $684,000
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $457,345 - $700,776	-3,685 Reduced 27.29%	9,817 $1.3 Million
Q4 2020 Feb 08, 2021	SELL	$112.16 - $174.14 $752,705 - $1.17 Million	-6,711 Reduced 33.2%	13,502 $2.34 Million
Q3 2020 Dec 04, 2020	SELL	$58.05 - $111.31 $78,367 - $150,268	-1,350 Reduced 6.26%	20,213 $2.26 Million
Q3 2020 Nov 06, 2020	SELL	$58.05 - $111.31 $1.36 Million - $2.6 Million	-23,353 Reduced 51.99%	21,563 $2.41 Million
Q2 2020 Aug 17, 2020	BUY	$57.2 - $74.41 $865,893 - $1.13 Million	15,138 Added 50.84%	44,916 $2.66 Million
Q2 2020 Aug 11, 2020	SELL	$57.2 - $74.41 $251,908 - $327,701	-4,404 Reduced 12.88%	29,778 $2.47 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $343,897 - $577,181	6,028 Added 21.41%	34,182 $2.3 Million
Q4 2019 Feb 06, 2020	SELL	$68.3 - $93.8 $401,808 - $551,825	-5,883 Reduced 17.28%	28,154 $2.37 Million
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $582,473 - $920,884	-9,416 Reduced 21.67%	34,037 $2.61 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $207,469 - $310,712	-4,914 Reduced 10.16%	43,453 $2.68 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $380,132 - $667,491	-11,894 Reduced 19.74%	48,367 $2.33 Million
Q3 2018 Nov 08, 2018	SELL	$32.0 - $52.4 $437,184 - $715,888	-13,662 Reduced 18.48%	60,261 $3.16 Million
Q2 2018 Aug 03, 2018	BUY	$19.85 - $32.0 $1.09 Million - $1.76 Million	55,000 Added 290.65%	73,923 $2.31 Million
Q1 2018 May 11, 2018	BUY	$19.3 - $23.65 $154 - $189	8 Added 0.04%	18,923 $412,000
Q4 2017 Feb 08, 2018	SELL	$16.3 - $21.9 $17,848 - $23,980	-1,095 Reduced 5.47%	18,915 $382,000
Q3 2017 Nov 06, 2017	BUY	$18.05 - $21.75 $361,180 - $435,217	20,010	20,010 $397,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$207 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$202 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$135 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$73.6 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$51.8 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.79B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account